Stock Analiz

AdaptHealth Corp. (AHCO) financials: revenue, earnings and cash flow

Fiscal 2018–2025 + TTM · from SEC filings · data as of November 13, 2026

Summary

AdaptHealth’s revenue went from $345M in fiscal 2018 to $3.2B in fiscal 2025, growth of about 37.7% a year.

Net income in fiscal 2025 was -$71M, a net margin of -2.2%; the best year in this period was 2021 with $156M.

Over the twelve months to September 30, 2026, revenue was $3.4B and net income -$407M.

Free cash flow was $219M in fiscal 2025 and positive in 7 of the 8 years shown.

The diluted share count rose 1036% over the period (dilution).

Revenue, profit and cash flow by year

Revenue
2018: $345M20182019: $530M20192020: $1.1B20202021: $2.5B20212022: $3.0B20222023: $3.2B20232024: $3.3B20242025: $3.2B2025$3.2B
Net income
2018: $23M20182019: -$21M20192020: -$162M20202021: $156M20212022: $69M20222023: -$679M20232024: $90M20242025: -$71M2025-$71M
Free cash flow
2018: $58M20182019: $39M20192020: $156M20202021: $72M20212022: -$18M20222023: $143M20232024: $236M20242025: $219M2025$219M
EPS (diluted)
2018: $1.9520182019: $-0.9520192020: $-3.0820202021: $0.6720212022: $0.3320222023: $-5.3120232024: $0.6120242025: $-0.522025$-0.52

Income statement

Fiscal yearTTM20252024202320222021202020192018
Revenue$3.4B$3.2B$3.3B$3.2B$3.0B$2.5B$1.1B$530M$345M
Gross profit$560M$609M$681M$624M$580M$446M$158M$89M$52M
Operating income-$320M$91M$264M-$598M$190M$226M$71M$29M$31M
Net income-$407M-$71M$90M-$679M$69M$156M-$162M-$21M$23M
EPS (diluted)$-2.98$-0.52$0.61$-5.31$0.33$0.67$-3.08$-0.95$1.95
R&D—————————
Revenue growth—−0.5%+1.9%+7.7%+21.0%+132.3%+99.5%+53.4%—

Cash flow

Fiscal yearTTM20252024202320222021202020192018
Operating cash flow$579M$602M$542M$481M$374M$276M$196M$60M$68M
Capital spending-$497M-$382M-$306M-$337M-$391M-$203M-$40M-$21M-$10M
Free cash flow$82M$219M$236M$143M-$18M$72M$156M$39M$58M
Dividends paid—$0$0$0$0$0$0$0$0
Buybacks—$0$0$29M$14M$0$0$20M—
Stock-based pay$18M$22M$15M$22M$22M$25M$19M$11M$883373

Balance sheet

Fiscal yearTTM20252024202320222021202020192018
Cash—$106M$110M$77M$46M$150M$100M$77M$947098
Debt—$1.9B$2.1B$2.3B$2.3B$2.4B$785M$397M$134M
Equity—$1.5B$1.6B$1.5B$2.2B$2.1B$355M-$39M$5M
Total assets—$4.3B$4.5B$4.5B$5.2B$5.3B$1.8B$547M$369M
Shares (diluted)136M135M136M134M139M133M52M23M12M

Margins and returns

Fiscal yearTTM20252024202320222021202020192018
Gross margin16.3%18.8%20.9%19.5%19.5%18.1%14.9%16.8%15.0%
Operating margin-9.3%2.8%8.1%-18.7%6.4%9.2%6.8%5.5%9.0%
Net margin-11.8%-2.2%2.8%-21.2%2.3%6.4%-15.3%-4.0%6.7%
FCF margin2.4%6.8%7.2%4.5%-0.6%2.9%14.8%7.4%16.9%
ROIC—2.1%5.0%-15.0%3.2%4.2%5.9%6.5%17.6%
ROE—-4.7%5.8%-46.6%3.2%7.6%-45.5%55.0%465.2%

Frequently asked questions

What is AdaptHealth’s annual revenue?

$3.2B in fiscal 2025 and $3.4B over the twelve months to September 30, 2026.

How much profit does AdaptHealth make?

Net income was -$71M in fiscal 2025 (net margin -2.2%).

Is AdaptHealth’s revenue growing?

No: revenue fell 0.5% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.